Literature DB >> 34249624

Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.

Qin-He Zhang1, Ying Zhao1, Shi-Feng Tian1, Lu-Han Xie2, Li-Hua Chen1, An-Liang Chen1, Nan Wang1, Qing-Wei Song1, Hao-Nan Zhang1, Li-Zhi Xie3, Zhi-Wei Shen4, Ai-Lian Liu1.   

Abstract

BACKGROUND: Accurate and early assessment of the hepatic fat content is crucial for patients with nonalcoholic fatty liver disease (NAFLD). For years, magnetic resonance imaging (MRI) has been considered the optimal noninvasive method for the assessment of fat accumulation. To avoid time-consuming manual placement of multiple regions of interest (ROI), the use of whole-liver segmentation has been proposed to measure liver fat, mainly for heterogeneous fat deposition. However, it remains uncertain whether the hepatic mean fat fraction (FF) obtained by whole-liver segmentation with the inclusion of intrahepatic vasculature is consistent with the traditional ROI sampling method. In this study, we assessed the accuracy of hepatic mean FF obtained by whole-liver segmentation in patients of NAFLD with different severities using the ROI sampling method as a reference standard.
METHODS: Hepatic FFs were measured by whole-liver segmentation and the ROI sampling method (reference standard) using MRI scanning with the iterative decomposition of water and fat with echo an asymmetry at least-square estimation-iron quantification (IDEAL-IQ) sequence. SPSS version 25.0 software was used to analyze the correlation and consistency of data between the two methods.
RESULTS: There was a strong correlation in hepatic FF between whole-liver segmentation and the ROI sampling method in healthy, mild, and moderate steatosis patients (r = 0.943, 0.990, and 0.961, respectively). Bland-Altman analysis showed a small bias of +0.50±0.27 and +0.05±0.30, which indicated a small overestimation when using whole-liver segmentation in healthy subjects and mild NAFLD patients. The 95% limits of agreement ranged from +1.02 to -0.03, and from +0.65 to -0.55, respectively. However, a small bias of -0.96±0.77 was also evident, which indicated a small underestimation when using whole-liver segmentation in moderate NAFLD patients. The 95% limits of agreement ranged from +0.56 to -2.48.
CONCLUSIONS: Due to inclusion of the intrahepatic vasculature, whole-liver segmentation has some effects on hepatic FF assessment in patients with different NAFLD severities; yet, it does not significantly affect the assessment of whole-liver FF in MRI FF maps. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Hepatic fat; magnetic resonance imaging (MRI); nonalcoholic fatty liver disease (NAFLD); whole-liver segmentation

Year:  2021        PMID: 34249624      PMCID: PMC8250014          DOI: 10.21037/qims-20-989

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  25 in total

1.  MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.

Authors:  Kim-Nhien Vu; Guillaume Gilbert; Marianne Chalut; Miguel Chagnon; Gabriel Chartrand; An Tang
Journal:  J Magn Reson Imaging       Date:  2015-11-04       Impact factor: 4.813

2.  Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals.

Authors:  Bo Kobberø Lauridsen; Stefan Stender; Thomas Skårup Kristensen; Klaus Fuglsang Kofoed; Lars Køber; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2018-02-01       Impact factor: 29.983

3.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Authors:  Vlad Ratziu; Frédéric Charlotte; Agnès Heurtier; Sophie Gombert; Philippe Giral; Eric Bruckert; André Grimaldi; Frédérique Capron; Thierry Poynard
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

4.  Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.

Authors:  Sina Meisamy; Catherine D G Hines; Gavin Hamilton; Claude B Sirlin; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

5.  Association of pancreatic fat content with type II diabetes mellitus.

Authors:  C Nadarajah; G Fananapazir; E Cui; J Gichoya; N Thayalan; M Asare-Sawiri; C O Menias; K Sandrasegaran
Journal:  Clin Radiol       Date:  2019-11-08       Impact factor: 2.350

6.  Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.

Authors:  Inpyeong Hwang; Jeong Min Lee; Kyoung Bun Lee; Jeong Hee Yoon; Berthold Kiefer; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2014-02-12       Impact factor: 11.105

7.  The Liver Fat Fraction and Abdominal Subcutaneous and Visceral Fat Volume Distribution in Normal-Weight, Overweight, and Obese Children Using a New Magnetic Resonance Imaging Technique.

Authors:  Berhan Pirimoglu; Recep Sade; Ali Islek; Mecit Kantarci
Journal:  J Comput Assist Tomogr       Date:  2019 Mar/Apr       Impact factor: 1.826

8.  Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.

Authors:  Bo-Kyeong Kang; Mimi Kim; Soon-Young Song; Dae Won Jun; Kiseok Jang
Journal:  Br J Radiol       Date:  2017-11-08       Impact factor: 3.039

9.  Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.

Authors:  Peter M Graffy; Veit Sandfort; Ronald M Summers; Perry J Pickhardt
Journal:  Radiology       Date:  2019-09-17       Impact factor: 11.105

10.  Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed?

Authors:  Qian Wang; Feng Ye; Peiqing Ma; Feng Chen; Yiqun Che; Xinming Zhao; Li Yang
Journal:  J Int Med Res       Date:  2019-03-12       Impact factor: 1.671

View more
  4 in total

1.  Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores.

Authors:  Jie Zhou; Feng Yan; Jinshun Xu; Qiang Lu; Xianglan Zhu; Binyang Gao; Huan Zhang; Rui Yang; Yan Luo
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Computed Tomography Image Analysis of Body Fat Based on Multi-Image Information.

Authors:  Wei Zang; Fengrui Zhu; Yang Yu
Journal:  Biomed Res Int       Date:  2022-06-20       Impact factor: 3.246

3.  How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review.

Authors:  You-Wei Li; Yang Jiao; Na Chen; Qiang Gao; Yu-Kun Chen; Yuan-Fang Zhang; Qi-Ping Wen; Zong-Ming Zhang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

4.  Quantification of Fat Metaplasia in the Sacroiliac Joints of Patients With Axial Spondyloarthritis by Chemical Shift-Encoded MRI: A Diagnostic Trial.

Authors:  Dong Liu; Churong Lin; Budian Liu; Jun Qi; Huiquan Wen; Liudan Tu; Qiujing Wei; Qingcong Kong; Ya Xie; Jieruo Gu
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.